Comparison of slow-release piretanide and bendroflumethiazide in the treatment of mild to moderate hypertension
- PMID: 2680677
- DOI: 10.1177/030006058901700504
Comparison of slow-release piretanide and bendroflumethiazide in the treatment of mild to moderate hypertension
Abstract
After 4 weeks of placebo treatment, 76 hypertensive patients were randomly allocated to 6 or 12 mg/day piretanide, or 2.5 mg/day bendroflumethiazide for 12 weeks in a double-blind study. Piretanide was given in a slow-release formulation and bendroflumethiazide as a tablet. All three treatments produced a significant reduction in supine and erect systolic and diastolic blood pressures after 2 weeks, and this effect was maintained throughout the study. Normotension (i.e. supine diastolic pressure less than or equal to 95 mmHg) was achieved in 73% of the patients receiving 12 mg/day piretanide and in 57% receiving 6 mg/day piretanide compared with 72% receiving bendroflumethiazide (not significant). Overall, five patients were withdrawn due to increased diuresis: two patients on each dosage of piretanide and one receiving bendroflumethiazide. Three patients receiving 6 mg/day piretanide were withdrawn due to diastolic blood pressure rising above 120 mmHg. Other side-effects reported were mild and transient. There were no significant changes in serum creatinine, glucose or high-density lipoprotein cholesterol. A small, but non-significant rise in uric acid level was seen in all three groups. Clinically relevant hypokalaemia requiring potassium supplementation occurred in three patients receiving bendroflumethiazide.
Similar articles
-
The Hypertension in the Very Elderly Trial (HYVET). Rationale, methodology and comparison with previous trials.Drugs Aging. 1994 Sep;5(3):171-83. doi: 10.2165/00002512-199405030-00003. Drugs Aging. 1994. PMID: 7803945 Review.
-
Piretanide, a potassium stable diuretic, in the treatment of essential hypertension.Eur J Clin Pharmacol. 1984;27(4):407-14. doi: 10.1007/BF00549586. Eur J Clin Pharmacol. 1984. PMID: 6394349 Clinical Trial.
-
The effects of piretanide capsules on blood pressure during ergometric and isometric work loads in patients with mild to moderate essential hypertension.Pharmatherapeutica. 1985;4(6):356-66. Pharmatherapeutica. 1985. PMID: 4080753
-
Piretanide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.Drugs. 1985 Jun;29(6):489-530. doi: 10.2165/00003495-198529060-00002. Drugs. 1985. PMID: 3891305 Review.
-
Piretanide, a potassium stable diuretic, in the treatment of essential hypertension: a double-blind comparison of two formulations.J Int Med Res. 1985;13(1):31-9. doi: 10.1177/030006058501300105. J Int Med Res. 1985. PMID: 3884409 Clinical Trial.
Cited by
-
Thiazide Diuretic-Induced Change in Fasting Plasma Glucose: a Meta-analysis of Randomized Clinical Trials.J Gen Intern Med. 2020 Jun;35(6):1849-1860. doi: 10.1007/s11606-020-05731-3. Epub 2020 Mar 10. J Gen Intern Med. 2020. PMID: 32157653 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical